explore -WSS

explore

author：knowledge 2025-09-30 23:06:52 - browse：29436

Diversity in clinical trials concept — Adobe

The persistent lack of diversity among participants in clinical trials is a critical issue that is harming both populations that have long been left out of pivotal medical studies and the entire biomedical research enterprise, according to the authors of a report released Tuesday by the National Academies of Sciences, Engineering and Medicine.

Describing the need to move away from trials that focus largely on white men as “urgent,” the report’s authors called for a paradigm shift that gives less power to institutions that fund and conduct clinical research and more to communities under study. The sternly worded report said funding to include and recruit more diverse participants should be a priority that is enforced and said such investments could eventually lead to massive cost savings as the nation’s health disparities are reduced.

“An equitable clinical research enterprise would include trials and studies that match the demographics of the disease burden under study,” the report said. “However, we remain far from achieving this goal.”

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Guidelines to prevent youth baseball injuries need more muscle
Next article： CDC advisers recommend seasonal use of Pfizer RSV shot

WSS

Thermo Fisher plant for manufacturing gene therapies to expand

Artificial intelligence use in health care faces greater scrutiny in 2024

How AI helped researchers track recovery from depression

Resistance to opioid

AMAs digital advisors table RPM coding reform proposal, again

Lasker Awards 2023: Winners in biomedical research

Wikipedia

explore

hotspot

Wildfire smoke exposes gaps in outdoor worker protections

Senate HELP committee spars over health care workforce policies

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Changes to biosimilar regulatory framework must prioritize patients

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Websites selling Wegovy, Zepbound ingredients targeted by FDA

Medicare details structure of new drug price negotiation program

Congress considering partial increase for doctor pay in Medicare

Virginia high school admissions case could be legal follow

Biotech lab space demand falls sharply

Wikipedia

Readout LOUD podcast: possible new ALS drug, artificial wombs

Experts study whether long Covid risk adds up with each reinfection

Drug for rare kidney disease narrowly misses mark in clinical trial

Here’s what’s in the FDA plan to include pregnant women in clinical trials

Senate HELP committee spars over health care workforce policies

Report cites 'urgent' need to recruit more diverse clinical trial participants

hotspot

entertainment

explore

explore